Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Vertex Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	4,674,700)	4,569,600)	5,239,200)	4,580,100)	9,158,000)	10,369,100)	11,110,200)	10,151,100)	9,289,900)	10,504,000)	9,171,500)	8,702,200)	7,600,100)	6,795,000)	6,275,698)	6,063,678)	6,304,330)	5,988,187)	5,358,087)	4,831,332)	3,593,412)
Marketable securities	1,526,500)	1,546,300)	1,285,300)	1,215,400)	1,013,300)	849,200)	818,000)	1,085,200)	1,124,200)	274,500)	599,200)	551,200)	638,000)	729,900)	685,187)	644,315)	619,638)	670,710)	792,971)	619,437)	596,984)
Accounts receivable, net	1,805,100)	1,609,400)	1,750,600)	1,656,100)	1,793,200)	1,563,400)	1,538,700)	1,556,200)	1,547,800)	1,442,200)	1,385,200)	1,332,900)	1,292,800)	1,136,800)	1,100,372)	929,142)	977,551)	885,352)	791,917)	791,768)	845,269)
Inventories	1,359,700)	1,205,400)	1,079,800)	914,600)	813,100)	738,800)	688,700)	603,500)	535,100)	460,600)	388,200)	367,700)	338,900)	353,100)	333,456)	321,620)	298,863)	280,777)	245,460)	219,218)	187,087)
Prepaid expenses and other current assets	642,800)	665,700)	449,200)	575,400)	511,100)	623,700)	540,200)	476,900)	468,700)	553,500)	726,900)	549,500)	491,500)	545,800)	457,827)	498,759)	338,925)	308,353)	270,021)	232,565)	223,648)
Current assets	10,008,800)	9,596,400)	9,804,100)	8,941,600)	13,288,700)	14,144,200)	14,695,800)	13,872,900)	12,965,700)	13,234,800)	12,271,000)	11,503,500)	10,361,300)	9,560,600)	8,852,540)	8,457,514)	8,539,307)	8,133,379)	7,458,456)	6,694,320)	5,446,400)
Property and equipment, net	1,295,900)	1,227,800)	1,117,800)	1,200,900)	1,172,800)	1,159,300)	1,124,000)	1,122,400)	1,111,700)	1,108,400)	1,118,700)	1,100,100)	1,107,400)	1,094,100)	1,042,347)	1,021,233)	986,123)	958,534)	920,913)	728,357)	736,303)
Goodwill	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,088,000)	1,075,200)	1,002,200)	1,002,200)	1,002,200)	1,002,158)	1,002,158)	1,002,158)	1,002,158)	1,002,158)	1,002,158)	1,002,158)
Other intangible assets, net	441,200)	825,900)	831,600)	837,500)	834,900)	839,900)	603,600)	603,600)	603,600)	603,600)	603,600)	387,000)	400,000)	400,000)	400,000)	400,000)	400,000)	400,000)	400,000)	400,000)	400,000)
Deferred tax assets	2,544,300)	2,331,100)	2,308,900)	2,185,600)	1,963,000)	1,812,100)	1,729,100)	1,538,000)	1,359,900)	1,246,900)	1,162,700)	1,143,800)	945,500)	934,500)	933,839)	952,808)	815,890)	882,779)	1,147,816)	1,214,968)	1,147,705)
Operating lease assets	1,338,500)	1,356,800)	1,396,100)	569,800)	312,900)	293,600)	310,500)	324,300)	336,300)	347,400)	342,700)	318,300)	329,000)	330,300)	312,343)	316,874)	322,319)	325,564)	—)	—)	—)
Long-term marketable securities	5,156,500)	5,107,900)	4,703,500)	4,393,100)	4,381,400)	2,497,800)	1,700,000)	1,357,300)	1,081,500)	112,200)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other assets	1,007,300)	999,300)	990,200)	915,600)	875,700)	895,300)	475,200)	442,700)	427,500)	409,600)	132,500)	127,300)	110,700)	110,800)	75,518)	71,099)	49,262)	49,394)	372,290)	176,564)	160,635)
Long-term assets	12,871,700)	12,936,800)	12,436,100)	11,190,500)	10,628,700)	8,586,000)	7,030,400)	6,476,300)	6,008,500)	4,916,100)	4,435,400)	4,078,700)	3,894,800)	3,871,900)	3,766,205)	3,764,172)	3,575,752)	3,618,429)	3,843,177)	3,522,047)	3,446,801)
Total assets	22,880,500)	22,533,200)	22,240,200)	20,132,100)	23,917,400)	22,730,200)	21,726,200)	20,349,200)	18,974,200)	18,150,900)	16,706,400)	15,582,200)	14,256,100)	13,432,500)	12,618,745)	12,221,686)	12,115,059)	11,751,808)	11,301,633)	10,216,367)	8,893,201)

Cash and Cash Equivalents: There is a general upward trend in cash and cash equivalents from March 2020 through March 2023, reaching a peak of over 11 billion USD. However, from March 2023 onward, the amount shows a notable decline, dropping to approximately 4.7 billion USD by March 2025. This indicates increased cash utilization or disbursement in the later period.
Marketable Securities: Marketable securities fluctuate moderately over the reported periods. Initial amounts vary around 600 to 700 million USD, with a dip in late 2022 and early 2023, followed by a rebound to over 1.5 billion USD by early 2025, suggesting periodic reallocation into marketable securities.
Accounts Receivable, Net: Accounts receivable generally increase over time, rising from approximately 845 million USD in March 2020 to peaks above 1.8 billion USD by March 2025. This steady rise indicates growth in sales or services rendered with payment pending, potentially reflecting expanded business operations.
Inventories: Inventories more than sextuple from 187 million USD in early 2020 to nearly 1.36 billion USD by March 2025. This continuous growth suggests either stockpiling in anticipation of demand or slower inventory turnover, which warrants further operational review.
Prepaid Expenses and Other Current Assets: There is variability with no clear consistent trend. The value peaks at around 726 million USD in late 2022 but declines afterward, ending near 643 million USD in March 2025. Fluctuations may reflect timing differences in expenditures and billing cycles.
Current Assets: Current assets overall increase steadily from around 5.4 billion USD to a peak of almost 14.7 billion USD by late 2023, then decline to about 10 billion USD by March 2025, mirroring the cash and equivalents' trend and suggesting a possible reduction in short-term liquidity.
Property and Equipment, Net: Property and equipment values show a consistent upward trend, growing from approximately 736 million USD in March 2020 to nearly 1.3 billion USD in early 2025, indicating ongoing investment in physical assets.
Goodwill: Goodwill remains mostly stable around 1 billion USD with a small step-up in late 2022, possibly due to acquisition activity or revaluation adjustments.
Other Intangible Assets, Net: The value is constant at 400 million USD through 2021 then spikes to over 600 million USD in late 2022, followed by a substantial increase to over 800 million USD by 2023, before a sharp decline to approximately 441 million USD in early 2025. This pattern may reflect amortization practices or asset impairment events.
Deferred Tax Assets: Deferred tax assets fluctuate but primarily increase from about 1.15 billion USD to over 2.5 billion USD by March 2025, indicating recognition of tax benefits potentially linked to losses or timing differences in expenses and revenues.
Operating Lease Assets: Operating lease assets appear from late 2020, initially stable around 320-350 million USD, then sharply increase to over 1.3 billion USD by late 2024, before slightly declining. This rise might be related to adoption or changes in lease accounting standards or new lease agreements.
Long-term Marketable Securities: This category emerges from late 2022, with a rapid rise to more than 5 billion USD by early 2025, suggesting strategic long-term investment accumulation starting from that period.
Other Assets: Other assets show variability, starting from approximately 160 million USD, with a strong increase in 2023 reaching near 900 million USD, and stabilizing close to 1 billion USD afterward, indicating possible acquisitions or revised asset valuations.
Long-term Assets: Long-term assets generally increase from about 3.4 billion USD in early 2020 to a peak exceeding 12.9 billion USD by early 2025, reflecting sustained investments in non-current asset categories over time.
Total Assets: Total assets climb consistently from roughly 8.9 billion USD to over 22.7 billion USD by late 2024, with minor fluctuations near the end of the period but maintaining above 22 billion USD. This overall growth denotes expanded asset base and corporate scaling.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data